Beutel, Goodman & Co’s Abbott ABT Stock Holding History

Beutel, Goodman & Co’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.24M	Sell	22,670 -1,000	-4%	-$104K	0.02%	90
2026 Q2	$2.15M	Sell	23,670 -900	-4%	-$82.1K	0.02%	95
2026 Q1	$2.52M	Sell	24,570 -1,530	-6%	-$173K	0.02%	92
2025 Q4	$3.27M	Sell	26,100 -1,300	-5%	-$166K	0.02%	81
2025 Q3	$3.67M	Sell	27,400 -200	-0.7%	-$26.3K	0.02%	80
2025 Q2	$3.75M	Sell	27,600 -7,198	-21%	-$949K	0.02%	80
2025 Q1	$4.62M	Buy	34,798 +33,298	+2,220%	+$4.24M	0.03%	80
2024 Q4	$169K	Hold	1,500	–	–	﹤0.01%	73
2024 Q3	$171K	Buy	+1,500	New	+$165K	﹤0.01%	72
2023 Q1	–	Sell	-200	Closed	-$21K	–	75
2022 Q4	$21K	Hold	200	–	–	﹤0.01%	75
2022 Q3	$19K	Buy	+200	New	+$21.3K	﹤0.01%	72

Other funds holding ABT

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Beutel, Goodman & Co's ABT Position: Q3 2026 in Review

Beutel, Goodman & Co reduced its Abbott (ABT) stake by 4.2% in Q3 2026, selling an estimated $104K and leaving 22,670 shares worth $2.24M. The position accounts for 0.02% of the portfolio, ranked #90.

Beutel, Goodman & Co first reported a position in ABT in Q3 2022 and has held it in 11 quarters since. The position peaked at $4.62M in Q1 2025. 2,662 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

Beutel, Goodman & Co held 22,670 shares of Abbott worth $2.24M as of Q3 2026.
Beutel, Goodman & Co sold 1,000 Abbott shares in Q3 2026, an estimated $104K.
Abbott made up 0.02% of Beutel, Goodman & Co's portfolio in Q3 2026, its #90 holding.
Beutel, Goodman & Co first reported a position in Abbott in Q3 2022 and has held it in 11 quarters since.
Beutel, Goodman & Co's Abbott position peaked at $4.62M in Q1 2025.
2,662 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Beutel, Goodman & Co's 13F filing for Q3 2026, filed 4 Nov 2026.